©CUTISS

Interview with Daniela Marino on Moneycab.com

“The B round will need to provide 30-40 million CHF to support the market access.” by Patrick Gunti Moneycab.com: Ms. Marino, Cutiss has developed a revolutionary method to produce human skin in the lab. How did that happen? In 2001 the Tissue Biology Reseach Unit, a research lab of the Department of Surgery of the University Children’s hospital in Zurich started working on skin bio-engineering to solve an unmet clinical need mostly connected to burns. Unfortunately, standard of care to treat large, deep burns is scarce and ineffective leading very often to highly debilitating, disfiguring scarring. Via personalized skin tissue bio-engineering one could permanently treat large wound surfaces and minimize the scarring.
Scroll to Top

Newsletter

Would you like to contact us as a journalist?

This website uses cookies to ensure you get the best experience on our website.